Feasibility of Cell Therapy in Multiple Sclerosis: A Systematic Review of 83 Studies

Multiple Sclerosis is an inflammatory disease of the central nervous system in which T cells experience a second phase of activation, which ultimately leads to axonal demyelination and neurological disability. The recent advances in stem cell therapies may serve as potential treatments for neurologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ardeshiry lajimi, Abdolreza, Hagh, Majid Farshdousti, Saki, Najmaldin, Mortaz, Esmaeil, Soleimani, Masoud, Rahim, Fakher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2013
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913133/
https://www.ncbi.nlm.nih.gov/pubmed/24505515
Descripción
Sumario:Multiple Sclerosis is an inflammatory disease of the central nervous system in which T cells experience a second phase of activation, which ultimately leads to axonal demyelination and neurological disability. The recent advances in stem cell therapies may serve as potential treatments for neurological disorders. There are broad types of stem cells such as neural, embryonic, mesenchymal and hematopoietic stem cells with unprecedented hope in treating many debilitating diseases. In this paper we will review the substantial literature regarding experimental and clinical use of these stem cells and possible mechanisms in the treatment of MS. These results may pave the road for the utilization of stem cells for the treatment of MS.

Ejemplares similares